Adult Pulmonary Vascular Disease

Chemotherapy-induced pulmonary hypertension: role of alkylating agents

Benoît Ranchoux, Sven Günther, Rozenn Quarck, Marie-Camille Chaumais, Peter Dorfmüller, FabriceAntigny, Sébastien J. Dumas, Nicolas Raymond, Edmund Lau, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Gérald Simonneau, Kurt Stenmark, Sylvia Cohen-Kaminsky, Marc Humbert, David Montani, Frédéric PerrosUniversité Paris-Sud and Hôpital de Bicêtre. Centre Chirurgical Marie Lannelongue. Assistance Publique des Hôpitaux de Paris. KU Leuven. University of […]

Chemotherapy-induced pulmonary hypertension: role of alkylating agents Read More »

End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment

Anna R. Hemnes, Meredith E. Pugh, Alexander L. Newman, Ivan M. Robbins, James Tolle, Eric D. Austin, John H. NewmanVanderbilt University Medical Center. United States ChestChest 2011; 140: 1267-1273DOI: 10.1378/chest.11-0155 AbstractBackground: CO(2) excretion is impaired in pulmonary arterial hypertension (PAH) due to underlying vascular obstruction and increased dead space. Our aim was to determine whether resting end

End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment Read More »

Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis

Thomas P. Doyle, James E. Loyd, Ivan M. RobbinsVanderbilt University School of Medicine.United States American Journal of Respiratory and Critical Care MedicineAm J Repir Crit Care Med 2001; 164: 657-660DOI: 10.1164/ajrccm.164.4.2012132 AbstractMediastinal fibrosis is a rare consequence of infection with the fungus Histoplasma capsulatum that can lead to occlusion of large pulmonary arteries and veins and

Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis Read More »

Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis

Amanda L. Cook, Lourdes R. Prieto, Jeffrey W. Delaney, John F. RhodesDuke University Medical Center.United States American Journal of CardiologyAm J Cardiol 2006; 98: 407-410DOI: 10.1016/j.amjcard.2006.02.049 AbstractAfter radiofrequency ablation for atrial fibrillation, patients may develop pulmonary vein stenoses requiring stent angioplasty. The treatment options for when such patients develop in-stent stenoses are poorly defined. The investigators

Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis Read More »

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension

Franz P. Rischard, Roberto J. Bernardo, Rebecca R. Vanderpool, Deborah H. Kwon, Tuschar Acharya, Margaret M. Park, Austin Katrynuik, Michael Insel, Saad Kubba, Roberto Badagliacca, A. Brett Larive, Robert Naeije, Joe G. N. Garcia, Gerald J. Beck, Serpil C. Erzurum, Robert P. Frantz, Paul M. Hassoun, Anna R. Hemnes, Nicholas S. Hill, Evelyn M. Horn,

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension Read More »

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension

Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John WortHospital del Mar. Stellenbosch University and Tygerberg Hospital. University of Crete School of Medicine. The University of Chicago. Johns Hopkins University. Bayer AG. University of California Los Angeles

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension Read More »

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Susanne J. Maurer, Veronika Habdank, Jürgen Hörer, Peter Ewert, Oktay TutarelGerman Heart Centre Munich and Technical University of Munich. Ludwig-Maximilians Universität.Germany Journal of Clinical MedicineJ Clin Med 2023; 12DOI: 10.3390/jcm12093101 AbstractBackground: About 5-10% of adults with congenital heart disease (ACHD) will develop pulmonary arterial hypertension (PAH), which is associated with significant mortality. Studies on risk factors for

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Read More »

Fatal Association of Eisenmenger Syndrome and Severe Preeclampsia

Said Benlamkaddem, Fatima Bouyermane, Djoudline Doughmi, Mohamed Adnane Berdai, Mustapha HarandouHassan II University Hospital. Sidi Mohamed Ben Abdellah University. Morocco CureusCureus 2023; 15DOI: 10.7759/cureus.37836 AbstractEisenmenger syndrome (ES) is the end stage of pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD), which can occur in patients with large, unrepaired cardiac shunts (ventricular septal defects (VSD),

Fatal Association of Eisenmenger Syndrome and Severe Preeclampsia Read More »

Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study

Mario Naranjo, Erika B. Rosenzweig, Anna B. Hemnes, Miriam Jacob, Ankit Desai, Nicholas S. Hill, A. Brett Larive, J. Emanuel Finet, Jane Leopold, Evelyn Horn, Robert Frantz, Frans Rischard, Serpil Erzurum, Gerald Beck, Stephen C. Mathai, Paul M. HassounJohns Hopkins University. Columbia University. Vanderbilt University Medical Center. Cleveland Clinic. University of Arizona College of Medicine.

Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study Read More »

Metabolomic differences in connective tissue disease-associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort

Catherine E. Simpson, Anna R. Hemnes, Megan Griffiths, Gabriele Grunig, W. H. Wison Tang, Joe G. N. Garcia, John Barnard, Suzy A. Comhair, Rachel L. Damico, Stephen C. Mathai, Paul M. Hassoun, the PVDOMICS Study GroupJohns Hopkins University. Vanderbilt University. University of Texas Southwestern Medical Center. New York University Grossman School of Medicine. Cleveland Clinic.

Metabolomic differences in connective tissue disease-associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort Read More »

Scroll to Top